Litcius/Paper detail

Metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial

Ida Pernicova, Stephen Kelly, Sharon Ajodha, Anju Sahdev, Jonathan P. Bestwick, Plamena Gabrovska, O. A. Akanle, Ramzi Ajjan, Blerina Kola, Marietta Stadler, William D. Fraser, Mirjam Christ‐Crain, Ashley Grossman, Costantino Pitzalis, Márta Korbonits

2020The Lancet Diabetes & Endocrinology86 citationsDOIOpen Access PDF

Topics & Concepts

MedicineMetforminPlaceboPrednisoloneGlucocorticoidDiabetes mellitusInternal medicineRandomized controlled trialSurgeryEndocrinologyPathologyAlternative medicineAdrenal Hormones and DisordersPituitary Gland Disorders and TreatmentsGrowth Hormone and Insulin-like Growth Factors